PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer

Triple-negative breast cancers (TNBCs) are the most aggressive breast cancers, and therapeutic options mainly rely on chemotherapy and immunotherapy. Although synthetic glucocorticoids (GCs) are given to alleviate the side effects of these treatments, GCs and their receptor, the glucocorticoid recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Noureddine, Lara Malik, Ablain, Julien, Surmieliova-Garnès, Ausra, Jacquemetton, Julien, Pham, Thuy Ha, Marangoni, Elisabetta, Schnitzler, Anne, Bieche, Ivan, Badran, Bassam, Trédan, Olivier, Hussein, Nader, Le Romancer, Muriel, Poulard, Coralie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400884/
https://www.ncbi.nlm.nih.gov/pubmed/37536978
http://dx.doi.org/10.26508/lsa.202302009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400884/
https://www.ncbi.nlm.nih.gov/pubmed/37536978
http://dx.doi.org/10.26508/lsa.202302009

Ejemplares similares